Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Plos One|April 16, 2026
Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe diseaseMazin Abdelghany, Fang Yu, Stephen Rennard, et al.Respiratory Research|June 17, 2010
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE studyDave Singh, Lisa Edwards, Ruth Tal-Singer, et al.BMC Cardiovascular Disorders|July 23, 2025
Electronic and regular cigarettes induce transcriptional and physiological changes in cardiomyocytesHesham Basma, Kajari Dhar, Jason Payne, et al.International Journal of Chronic Obstructive Pulmonary Disease|August 16, 2014
Influence of diet and obesity on COPD development and outcomesCorrine Hanson, Erica P Rutten, Emiel F M Wouters, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|May 21, 2013
Diet and vitamin D as risk factors for lung impairment and COPDCorrine Hanson, Erica P A Rutten, Emiel F M Wouters, et al.Chest|October 14, 2024
Editing Approaches to Treat Alpha-1 Antitrypsin DeficiencyDerek M Erion, Leah Y Liu, Christopher R Brown, et al.Respiratory Research|June 24, 2020
Improving the evaluation of COPD exacerbation treatment effects by accounting for early treatment discontinuations: a post-hoc analysis of randomized clinical trialsAgnieszka Król, Robert Palmér, Virginie Rondeau, et al.COPD|May 18, 2013
One-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPDAnthony D'Urzo, Edward Kerwin, Stephen Rennard, et al.BMC Cardiovascular Disorders|August 8, 2020
Electronic cigarette extract induced toxic effect in iPS-derived cardiomyocytesHesham Basma, Swetha Tatineni, Kajari Dhar, et al.The American Journal of Medicine|November 21, 2012
Inflammation in COPD: implications for managementSanjay Sethi, Donald A Mahler, Philip Marcus, et al.Pageof 10